BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31654857)

  • 21. Microbiome systems biology advancements for natural well-being.
    Chatterjee G; Negi S; Basu S; Faintuch J; O'Donovan A; Shukla P
    Sci Total Environ; 2022 Sep; 838(Pt 2):155915. PubMed ID: 35568180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota, metabolites and host immunity.
    Rooks MG; Garrett WS
    Nat Rev Immunol; 2016 May; 16(6):341-52. PubMed ID: 27231050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiome-Germline Interactions and Their Transgenerational Implications.
    Elgart M; Soen Y
    Bioessays; 2018 Apr; 40(4):e1700018. PubMed ID: 29266341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic engineering of human gut microbiome: Recent developments and future perspectives.
    Li P; Roos S; Luo H; Ji B; Nielsen J
    Metab Eng; 2023 Sep; 79():1-13. PubMed ID: 37364774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose alters the symbiotic relationships between gut microbiota and host physiology.
    AnhĂȘ FF; Barra NG; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E111-E116. PubMed ID: 31794261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Omics- and Metabolic Modeling-Assisted Deciphering of Human Microbiota Metabolism.
    Sieow BF; Nurminen TJ; Ling H; Chang MW
    Biotechnol J; 2019 Sep; 14(9):e1800445. PubMed ID: 31144773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence that gut microbiota impose a net cost on their butterfly host.
    Ravenscraft A; Kish N; Peay K; Boggs C
    Mol Ecol; 2019 Apr; 28(8):2100-2117. PubMed ID: 30803091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome therapeutics - Advances and challenges.
    Mimee M; Citorik RJ; Lu TK
    Adv Drug Deliv Rev; 2016 Oct; 105(Pt A):44-54. PubMed ID: 27158095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging frontiers of antibiotics use and their impacts on the human gut microbiome.
    Kumari R; Yadav Y; Misra R; Das U; Das Adhikari U; Malakar P; Dubey GP
    Microbiol Res; 2022 Oct; 263():127127. PubMed ID: 35914416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Enteric Pathogens to Probe the Gut Microbiota.
    Spiga L; Winter SE
    Trends Microbiol; 2019 Mar; 27(3):243-253. PubMed ID: 30545712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commensal Koch's postulates: establishing causation in human microbiota research.
    Neville BA; Forster SC; Lawley TD
    Curr Opin Microbiol; 2018 Apr; 42():47-52. PubMed ID: 29112885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K
    Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling.
    d'Hennezel E; Abubucker S; Murphy LO; Cullen TW
    mSystems; 2017; 2(6):. PubMed ID: 29152585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An expanding stage for commensal microbes in host immune regulation.
    Shi Y; Mu L
    Cell Mol Immunol; 2017 Apr; 14(4):339-348. PubMed ID: 28065939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in host-microbe metabolic axis].
    Pi Y; Gao K; Zhu W
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic Microbiomes on the Rise-Application in Deciphering the Role of Microbes in Host Health and Disease.
    Bolsega S; Bleich A; Basic M
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor.
    Erturk-Hasdemir D; Kasper DL
    Ann N Y Acad Sci; 2018 Apr; 1417(1):116-129. PubMed ID: 29528123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.